Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012		Sep. 30, 2013	Sep. 30, 2012
Net Sales	$ 13,734	$ 13,637		$ 42,694	$ 42,869
Cost of sales	11,716	11,368		35,526	35,853
Research and development expenses	418	434		1,270	1,245
Selling, general and administrative expenses	698	739		2,186	2,120
Amortization of intangibles	114	117		344	361
Restructuring charges	0	0		0	357
Equity in earnings of nonconsolidated affiliates	322	175		780	492
Sundry income (expense) - net	59	(21)		2,080	23
Interest income	11	10		29	26
Interest expense and amortization of debt discount	264	318		839	959
Income Before Income Taxes	916	825		5,418	2,515
Provision for income taxes	231	234		1,630	664
Net Income	685	591		3,788	1,851
Net income attributable to noncontrolling interests	6	9		49	38
Net Income Attributable to The Dow Chemical Company	679	582		3,739	1,813
Preferred stock dividends	85	85	[1]	255	255	[1]
Net Income Available for The Dow Chemical Company Common Stockholders	594	497		3,484	1,558
Per Common Share Data:
Earnings per common share - basic	$ 0.50	$ 0.42		$ 2.92	$ 1.32
Earnings per common share - diluted	$ 0.49	$ 0.42		$ 2.88	$ 1.31
Common stock dividends declared per share of common stock	$ 0.32	$ 0.32		$ 0.96	$ 0.89
Weighted-average common shares outstanding - basic	1,187.4	1,172.7		1,184.9	1,167.8
Weighted-average common shares outstanding - diluted	1,194.2	1,179.5		1,287.8	1,174.9
Depreciation	509	514		1,518	1,530
Capital Expenditures	$ 566	$ 622		$ 1,418	$ 1,605

[1] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the three-month period ended September 30, 2013 and the three- and nine-month periods ended September 30, 2012 because the effect of adding them back would have been antidilutive.